InAADR

Drug Information

Drug Name: Procyanidin B2 (29106-49-8)
PubChem ID: 122738
SMILES: C1[C@H]([C@H](OC2=C1C(=CC(=C2[C@@H]3[C@H]([C@H](OC4=CC(=CC(=C34)O)O)C5=CC(=C(C=C5)O)O)O)O)O)C6=CC(=C(C=C6)O)O)O
InchiKey: XFZJEEAOWLFHDH-NFJBMHMQSA-N
Therapeutic Category:

Computed Drug Properties

Molecular Weight (dalton): 578.526
LogP: 2.995
Ring Count: 4
Hydrogen Bond Acceptor Count: 12
Hydrogen Bond Donor Count: 10
Total Polar Surface Area: 220.76

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abdominal Pain MetaADEDB
Abnormal Movements MetaADEDB
Activated Partial Thromboplastin Time Prolonged MetaADEDB
Acute Generalised Exanthematous Pustulosis MetaADEDB
Acute Kidney Failure MetaADEDB
Acute Pancreatitis MetaADEDB
Acute Respiratory Distress Syndrome MetaADEDB
Alanine Aminotransferase Increased MetaADEDB
Allergic Dermatitis MetaADEDB
Allergic Vasculitis MetaADEDB
Anaemia MetaADEDB
Anal Sphincter Atony MetaADEDB
Angioedema MetaADEDB
Aortic Valve Disease MetaADEDB
Apathy MetaADEDB
Apoplexy MetaADEDB
Balance Disorder MetaADEDB
Basal Cell Carcinoma MetaADEDB
Bile Duct Stone MetaADEDB
Bladder Inflammation MetaADEDB
Blood Chloride Decreased MetaADEDB
Blood Creatinine Increased MetaADEDB
Blood Glucose Decreased MetaADEDB
Blood Potassium Decreased MetaADEDB
Blood Sodium MetaADEDB
Body Temperature MetaADEDB
Body Temperature Increased MetaADEDB
C-Reactive Protein Increased MetaADEDB
Cancer MetaADEDB
Cardiac Failure Acute MetaADEDB
Cheilitis MetaADEDB
Colitis MetaADEDB
Confabulation MetaADEDB
Cutaneous Vasculitis MetaADEDB
Cytolytic Hepatitis MetaADEDB
Dermatitides MetaADEDB
Dermatitis Medicamentosa MetaADEDB
Diplopia MetaADEDB
Disorder Lung MetaADEDB
Diverticulosis MetaADEDB
Drug Interaction MetaADEDB
Duodenal Ulcer MetaADEDB
Eczema MetaADEDB
Embolism Pulmonary MetaADEDB
Eosinophil Count Increased MetaADEDB
Escherichia Urinary Tract Infection MetaADEDB
Fatty Liver MetaADEDB
Febrile Bone Marrow Aplasia MetaADEDB
Flatulence MetaADEDB
Formication MetaADEDB
General Physical Condition MetaADEDB
General Physical Health Deterioration MetaADEDB
Globulinuria MetaADEDB
Goiter MetaADEDB
Haematoma MetaADEDB
Henoch-Schonlein Purpura MetaADEDB
Hepatic Enzyme MetaADEDB
Hypoalbuminaemia MetaADEDB
Hypokalaemia MetaADEDB
Hypotension Orthostatic MetaADEDB
Hypovolaemic Shock MetaADEDB
Infection Urinary Tract MetaADEDB
Influenza Like Illness MetaADEDB
International Normalised Ratio Increased MetaADEDB
Kidney Failure MetaADEDB
Lung Infection MetaADEDB
Metabolic Encephalopathy MetaADEDB
Mitral Valve Disease MetaADEDB
Motor Dysfunction MetaADEDB
Multiple Sclerosis MetaADEDB
Petechia MetaADEDB
Phlebothrombosis MetaADEDB
Platelet Count MetaADEDB
Prothrombin Level Decreased MetaADEDB
Psychomotor Skills Impaired MetaADEDB
Skin Erosion MetaADEDB
Social Avoidant Behaviour MetaADEDB
Torsade De Pointes MetaADEDB
Toxic Encephalopathy MetaADEDB
Transaminases Increased MetaADEDB

InAADR: Drug-Protein-ADRs database